Neuroimmunology Research Unit, Sagol School of Neuroscience, and The School of Psychological Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Neuroimmunology Research Unit, Sagol School of Neuroscience, and The School of Psychological Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Brain Behav Immun. 2019 Aug;80:170-178. doi: 10.1016/j.bbi.2019.03.005. Epub 2019 Mar 6.
The perioperative period holds disproportionate impact on long-term cancer outcomes. Nevertheless, perioperative interventions to improve long-term cancer outcomes are not clinical routines, including perioperative stress-reducing or immune-stimulating approaches. Here, mimicking the clinical setting of pre-operative distress, followed by surgery, we examined the separate and combined effects of these events on the efficacy of pre-operative immune stimulation in rats and mice, and on post-operative resistance to tumor metastasis of the syngeneic mammary adenocarcinoma MADB106 in F344 rats and the CT26 colon carcinoma in Balb/C mice. The novel immune stimulating agents, GLA-SE or CpG-C (TLR-4 and TLR-9 agonists, respectively), were employed pre-operatively. Sixteen hours of pre-operative behavioral stressors (i) lowered CpG-C induced plasma IL-12 levels, and reduced resistance to MADB106 and CT-26 experimental metastases, and (ii) worsened the deleterious effects of laparotomy on metastasis in both tumor models. In rats, these effects of pre-operative stress were further studied and successfully abolished by the glucocorticoid receptor antagonist RU-486. Additionally, in vitro studies indicated the dampening effect of corticosterone on immune stimulation. Last, we tested a perioperative integrated intervention in the context of pre-operative stress and laparotomy, based on (i) antagonizing the impact of glucocorticoids before surgery, (ii) activating anti-metastatic immunity perioperatively, and (iii) blocking excessive operative and post-operative adrenergic and prostanoid responses. This integrated intervention successfully and completely abolished the deleterious effects of stress and of surgery on post-operative resistance to experimental metastasis. Such and similar integrated approaches can be studied clinically in cancer patients.
围手术期对长期癌症结果有不成比例的影响。然而,改善长期癌症结果的围手术期干预措施并非临床常规,包括围手术期减轻应激或免疫刺激的方法。在这里,模拟术前焦虑的临床环境,接着是手术,我们研究了这些事件对术前免疫刺激在大鼠和小鼠中的疗效的单独和联合影响,以及对 F344 大鼠同源乳腺腺癌 MADB106 和 Balb/C 小鼠 CT26 结肠癌细胞术后抵抗转移的影响。使用了两种新型免疫刺激剂,GLA-SE 或 CpG-C(分别为 TLR-4 和 TLR-9 激动剂)进行术前治疗。16 小时的术前行为应激源(i)降低了 CpG-C 诱导的血浆 IL-12 水平,并降低了对 MADB106 和 CT-26 实验性转移的抵抗力,并且(ii)使剖腹手术对两种肿瘤模型转移的有害影响恶化。在大鼠中,进一步研究了术前应激的这些影响,并通过糖皮质激素受体拮抗剂 RU-486 成功消除。此外,体外研究表明皮质酮对免疫刺激有抑制作用。最后,我们在术前应激和剖腹手术的背景下测试了一种围手术期综合干预措施,基于(i)在手术前拮抗糖皮质激素的影响,(ii)围手术期激活抗转移免疫,以及(iii)阻断过度手术和术后儿茶酚胺和前列腺素反应。这种综合干预措施成功且完全消除了应激和手术对术后抵抗实验性转移的有害影响。可以在癌症患者中进行这种和类似的综合方法的临床研究。